Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections

Keyphrases

• All-cause Mortality 100%
• Multidrug-resistant Organisms 100%
• Infectious Diseases Consultation 100%
• Confidence Interval 54%
• Hazard Ratio 54%
• 30-day Mortality 27%
• Enterobacteriaceae 27%
• Infection-related Mortality 18%
• Enterococcus 18%
• Staphylococcus Aureus 18%
• Acinetobacter 18%
• 1-year Mortality 18%
• Pseudomonas 18%
• Polymicrobial Infection 18%
• Clinical Outcomes 9%
• Tertiary Care Hospital 9%
• Bronchoalveolar Lavage 9%
• High Mortality Rate 9%
• Cox Proportional Hazards Model 9%
• Propensity Score 9%
• 30-day Readmission 9%
• Readmission 9%
• Small Sample Size 9%
• Mortality Hazard 9%
• Readmission Rates 9%
• Retrospective Cohort 9%
• Inverse Weighting 9%
• Multidrug-resistant Staphylococcus Aureus 9%
• Staphylococcus Aureus Bloodstream Infection 9%
• Bronchial Wash 9%

Medicine and Dentistry

• Infection 100%
• All Cause Mortality 100%
• Infectious Disease 100%
• Hazard Ratio 54%
• Staphylococcus Aureus 27%
• Enterobacteriaceae 27%
• Acinetobacter 18%
• Pseudomonas 18%
• Enterococcus 18%
• Polymicrobial Infection 18%
• Proportional Hazards Model 9%
• Patient Referral 9%
• Identified Patient 9%
• Bloodstream Infection 9%
• Lung Lavage 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• All Cause Mortality 100%
• Diseases 100%
• Enterobacteriaceae 27%
• Staphylococcus Aureus 27%
• Enterococcus 18%
• Acinetobacter 18%
• Pseudomonas 18%
• Bloodstream Infection 9%